The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 study of carfilzomib, bendamustine, and dexamethasone (CBD) in newly diagnosed multiple myeloma patients.
 
Siyang Leng
No Relationships to Disclose
 
Alexander Wei
No Relationships to Disclose
 
Amer Assal
No Relationships to Disclose
 
Divaya Bhutani
No Relationships to Disclose
 
Gregory Baliko
No Relationships to Disclose
 
Julia Gould
No Relationships to Disclose
 
Ryan J Shelton
No Relationships to Disclose
 
Shannon Kelly
No Relationships to Disclose
 
Daniel Otap
No Relationships to Disclose
 
Markus Y Mapara
No Relationships to Disclose
 
Suzanne Lentzsch
Leadership - Caelum Biosciences
Stock and Other Ownership Interests - Caelum Biosciences
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb